Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Investigations into the role of eNOS-based platelet subpopulations in prostate cancer metastasis and angiogenesis

FY 2016-17

Summary
Prostate cancer (PCa) is the second most common malignancy diagnosed among men in Canada. In 2014, the Canadian Cancer Society estimated that about 23,600 new cases PCa were diagnosed across the country. The five-year survival of patients diagnosed with metastatic PCa is reported to be about 32%. Despite the success in early detection, we continue to lack predictive biomarkers to delineate which patients will potentially transform into more aggressive metastatic disease. Platelets are involved in hemostasis and thrombosis. In addition, a large body of evidence suggests that platelets play a crucial role in tumor growth and metastasis by a process known as tumor cell-induced platelet aggregation (TCIPA). Platelets have been shown to sequester and upon TCIPA secrete tumor angiogenesis regulating factors and to facilitate hematogenous metastasis. Previous work has demonstrated that an inverse relationship exists between TCIPA and nitric oxide (NO) production, as NO is an endogenous anti-platelet factor. Recent data demonstrate that platelet subpopulations exist based on differential expression of endothelial nitric oxide synthase (eNOS) and the ability to generate NO. Platelets lacking the ability to generate NO have been shown to be involved in the initiation of platelet aggregation, while NO generating platelets limit aggregate size. Moreover, these platelet subpopulations arise from megakaryocytes as a consequence of eNOS counter-regulating effects of IL-10 and IFN-g. Based on these new findings, we hypothesize that non-NO generating platelets may play a crucial role in PCa-induced platelet agggregation and metastasis, and that they may be a valuable biomarker for PCa metastatic spread or target for anti-metastatic therapy.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367323
Name
Rudzinski Jan K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigations into the role of eNOS-based platelet subpopulations in prostate cancer metastasis and angiogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenesis; Chick Embryo Chorioallantoic Membrane Model; Intra-Vital Imaging; Matrix Metalloproteinase; Metastasis; Nitric Oxide; Nitric Oxide Synthese; Platelets; Prostate Cancer
Abstract
Prostate cancer (PCa) is the second most common malignancy diagnosed among men in Canada. In 2014, the Canadian Cancer Society estimated that about 23,600 new cases PCa were diagnosed across the country. The five-year survival of patients diagnosed with metastatic PCa is reported to be about 32%. Despite the success in early detection, we continue to lack predictive biomarkers to delineate which patients will potentially transform into more aggressive metastatic disease. Platelets are involved in hemostasis and thrombosis. In addition, a large body of evidence suggests that platelets play a crucial role in tumor growth and metastasis by a process known as tumor cell-induced platelet aggregation (TCIPA). Platelets have been shown to sequester and upon TCIPA secrete tumor angiogenesis regulating factors and to facilitate hematogenous metastasis. Previous work has demonstrated that an inverse relationship exists between TCIPA and nitric oxide (NO) production, as NO is an endogenous anti-platelet factor. Recent data demonstrate that platelet subpopulations exist based on differential expression of endothelial nitric oxide synthase (eNOS) and the ability to generate NO. Platelets lacking the ability to generate NO have been shown to be involved in the initiation of platelet aggregation, while NO generating platelets limit aggregate size. Moreover, these platelet subpopulations arise from megakaryocytes as a consequence of eNOS counter-regulating effects of IL-10 and IFN-g. Based on these new findings, we hypothesize that non-NO generating platelets may play a crucial role in PCa-induced platelet agggregation and metastasis, and that they may be a valuable biomarker for PCa metastatic spread or target for anti-metastatic therapy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rudzinski, Jan K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~